Molecular characterization and virulence gene profiling of methicillin-resistant

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

21 citing papers in PubMed.

1. Multivalent nanobodies for potent and broad neutralization of Staphylococcus aureus toxins.Nature communications · 2026
   Article
2. One Health Genomic Analysis of Methicillin-Resistant Staphylococcus spp. From Humans, Cats, and Dogs in a Veterinary Hospital in Central Chile.Zoonoses and public health · 2026
   Article
3. Microbiology spectrum · 2026
   Observational
4. Global emergence and evolution ofmSystems · 2026
   Article
5. Prevalence, Antimicrobial Resistance, and Molecular Characteristics of MRSA in Saudi Arabia: A Retrospective Study.Microorganisms · 2026
   Article
6. MRSA in Tibet: high prevalence driven by the epidemic clone CC59-ST59-SCCFrontiers in microbiology · 2026
   Article
7. Methicillin-resistant Staphylococcus aureus (MRSA) infection in hospitalized patients is dominated by community-acquired strains: genomic epidemiological evidence.PloS one · 2026
   Article
8. Long-term impact of molecular epidemiology shifts of methicillin-resistantEmerging microbes & infections · 2025
   Article
9. A Paradigm Shift in SSTI Management: The Multifunctional Role of Extracellular Vesicles.International journal of molecular sciences · 2025
   Review
10. Clinical and molecular characteristics of Staphylococcus aureus isolates from patients with COVID-19 in Southwest China.BMC infectious diseases · 2025
    Article
11. Microbial Epidemiology and Antimicrobial Resistance of Bloodstream Infections in Hospitalized Patients During 2019-2023 in Xiangyang, China.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Article
12. Phenotypic and genotypic characteristics of mecA - positive oxacillin-sensitive Staphylococcus aureus isolated from patients with bloodstream infection in a tertiary hospital in Southern Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
13. Different evolution ofHeliyon · 2024
    Article
14. Genomic characterization and outbreak investigations of methicillin-resistantFrontiers in microbiology · 2024
    Article
15. Phylogenetic analysis and virulence characteristics of methicillin-resistantEmerging microbes & infections · 2023
    Article
16. Molecular Characteristics and Prevalence of Rifampin Resistance inAntibiotics (Basel, Switzerland) · 2023
    Article
17. Novel evidence on sepsis-inducing pathogens: from laboratory to bedside.Frontiers in microbiology · 2023
    Review
18. Characteristics of Virulent ST5-SCCInfection and drug resistance · 2023
    Article
19. Antibiotic susceptibility and clonal distribution ofFrontiers in cellular and infection microbiology · 2023
    Article
20. Molecular typing and characterization ofFrontiers in microbiology · 2023
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

9 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as